Seroatlas · Human Serome Atlas

CFHR3

Complement factor H-related protein 3

Also known as: CFHL3, DOWN16, FHR-3, FHR3, FHR3_HUMAN, HLF4

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q02985
Gene
CFHR3
Ensembl
ENSG00000116785
Chromosome
1
Canonical length
330 aa
Protein class
Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins
Subcellular location
Vesicles
Secretome location
Secreted to blood

OverviewNCBI Gene

The protein encoded by this gene is a secreted protein, which belongs to the complement factor H-related protein family. It binds to heparin, and may be involved in complement regulation. Mutations in this gene are associated with decreased risk of age-related macular degeneration, and with an increased risk of atypical hemolytic-uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Canonical amino-acid sequenceUniProt

330 residues, UniProt reviewed canonical sequence.

>Q02985|CFHR3
     1  MLLLINVILT LWVSCANGQV KPCDFPDIKH GGLFHENMRR PYFPVAVGKY YSYYCDEHFE
    61  TPSGSYWDYI HCTQNGWSPA VPCLRKCYFP YLENGYNQNY GRKFVQGNST EVACHPGYGL
   121  PKAQTTVTCT EKGWSPTPRC IRVRTCSKSD IEIENGFISE SSSIYILNKE IQYKCKPGYA
   181  TADGNSSGSI TCLQNGWSAQ PICINSSEKC GPPPPISNGD TTSFLLKVYV PQSRVEYQCQ
   241  PYYELQGSNY VTCSNGEWSE PPRCIHPCII TEENMNKNNI KLKGRSDRKY YAKTGDTIEF
   301  MCKLGYNANT SILSFQAVCR EGIVEYPRCE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CFHR3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.35
Highest tissue expression
367 nTPM

Expression across tissuesHPA

Tissue

  • liver: 367 nTPM
  • spleen: 0.4 nTPM
  • blood vessel: 0.3 nTPM
  • kidney: 0.3 nTPM
  • urinary bladder: 0.3 nTPM
  • adipose tissue: 0.2 nTPM

Single-cell type

  • hepatocytes: 1.1 nCPM
  • papillary tip epithelial cells: 0.5 nCPM
  • endometrial ciliated cells: 0.2 nCPM
  • renal connecting tubule cells: 0.2 nCPM
  • bergmann glia: 0.1 nCPM
  • distal convoluted tubule cells: 0.1 nCPM

Immune cell

  • basophil: 0.2 nTPM
  • neutrophil: 0.1 nTPM
  • NK-cell: 0.1 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM

Brain region

  • white matter: 2.9 nTPM
  • cerebral cortex: 2.3 nTPM
  • basal ganglia: 2.2 nTPM
  • amygdala: 2.1 nTPM
  • cerebellum: 2.1 nTPM
  • hippocampal formation: 2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CFHR3.

Disease | AllUniProt

Conditions CFHR3 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 123 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | ImmuneIEDB

Conditions an epitope on CFHR3 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.6
gnomAD pLI
0
gnomAD missense Z
0
DepMap mean gene effect
-0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CFHR3 as an antibody target. Whether an autoantibody or antibody against CFHR3 could matter depends on whether native CFHR3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CFHR3 is annotated as secreted, so native CFHR3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CFHR3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CFHR3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...